Logo CICANCER

Old CIC Events

How does nutrition impact cancer development? 07/10/2026

How does nutrition impact cancer development?

Nabil Djouder — CNIO, Madrid

Scientific seminars programme 07/10/2026

Scientific seminars programme

October–December —

Defensa de tesis: Implication of the repressor Capicua in KRAS-driven lung tumor formation and resistance to targeted therapies 25/09/2026

Defensa de tesis: Implication of the repressor Capicua in KRAS-driven lung tumor formation and resistance to targeted therapies

Irene Ballesteros González — Programa de Biología y Clínica del Cáncer

Regulatory programs associated with trastuzumab resistance in HER2-positive breast cancer 03/09/2026

Regulatory programs associated with trastuzumab resistance in HER2-positive breast cancer

Neda Mansouri — Centro de Investigación del Cáncer (CSIC, USAL, FICUS)

The immunological road to bone: the role of B cells in breast cancer bone metastasis 30/07/2026

The immunological road to bone: the role of B cells in breast cancer bone metastasis

Ana Teijeiro — National Institutes of Health (NIH) Bethesda, USA

Defensa de tesis doctoral: Desregulación inmune en gammapatía monoclonal y sus implicaciones en el control y progresión de la enfermedad 20/07/2026

Defensa de tesis doctoral: Desregulación inmune en gammapatía monoclonal y sus implicaciones en el control y progresión de la enfermedad

Oihane Pérez Escurza — Programa de doctorado de Biología y Clínica del Cáncer

Defensa de tesis doctoral: Deciphering the role of epitranscriptomic regulation in prostate cancer metastasis and chemotherapy resistance 17/07/2026

Defensa de tesis doctoral: Deciphering the role of epitranscriptomic regulation in prostate cancer metastasis and chemotherapy resistance

Óscar Monteagudo — Programa de doctorado de Biología y Clínica del Cáncer

The role of Pax5 in B-cell acute lymphoblastic leukemia 16/07/2026

The role of Pax5 in B-cell acute lymphoblastic leukemia

Belén María Ruiz Corzo — Centro de Investigación del Cáncer (CSIC, USAL, FICUS)

Targeting the Tumour Stroma with an Anti-FAP Antibody-Drug Conjugate 09/07/2026

Targeting the Tumour Stroma with an Anti-FAP Antibody-Drug Conjugate

Mónica Redondo — Centro de Investigación del Cáncer (CSIC,USAL,FICUS)

Study of the mechanisms involved in the acquired resistance to the monoclonal antibody isatuximab in multiple myeloma 02/07/2026

Study of the mechanisms involved in the acquired resistance to the monoclonal antibody isatuximab in multiple myeloma

Marta González Rodríguez — Centro de Investigación del Cáncer (CSIC-USAL-FICUS), Salamanca